文献速递角膜与眼表疾病

干眼症当前诊断与治疗进展

Update in Current Diagnostics and Therapeutics of Dry Eye Disease.
PubMed 文献 · Ophthalmology · 2017-01-01

本文综述干眼症(DED)诊断与治疗的最新进展。DED临床表现高度异质,诊断需结合症状、体征和临床检查,治疗需针对患者具体机制个体化。最新诊断方法包括泪膜渗透压、炎症生物标志物和睑板腺成像,治疗新选择包括抗炎治疗、睑板腺加热与挤压及巩膜接触镜。

要点

  • DED诊断需结合症状、体征和临床检查,单一指标会漏诊大量患者。
  • 泪膜渗透压、炎症生物标志物和睑板腺成像是值得关注的新诊断方法。
  • 抗炎治疗、睑板腺加热与挤压及巩膜接触镜是DED治疗的最新选择。

核心结论

  • DED诊断需综合症状、体征和临床检查,治疗应针对每例患者的具体机制进行个体化选择。
  • 泪膜渗透压、炎症生物标志物和睑板腺成像是DED最值得关注的新诊断方法。
  • 抗炎治疗、睑板腺加热与挤压及巩膜接触镜是DED治疗的最新选择之一。

研究设计与样本

  • 本文为综述,旨在总结近年使DED患者得以更好识别、分类和治疗的进展。

主要发现

  • DED是一组以泪膜功能不全和眼表刺激体征和/或症状为特征的异质性疾病。
  • DED临床表现高度可变,故诊断常基于症状、体征和临床检查的组合,因其中任何单一指标都会漏诊大量患者。
  • 治疗常需针对患者疾病涉及的具体机制进行个体化调整。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dry eye disease (DED) represents a heterogeneous group of conditions with tear film insufficiency and signs and/or symptoms of ocular surface irritation. The clinical manifestations of DED can be highly variable; hence the diagnosis is often based on a combination of symptoms, signs, and clinical tests, given that any one of these alone would miss a significant number of patients. Similarly, the treatment must often be tailored to each patient by targeting the specific mechanisms involved in his or her disease. The purpose of this review is to summarize recent advances that have allowed us to better recognize, categorize, and treat patients with DED. The most notable new diagnostic tests in DED are tear film osmolarity, inflammatory biomarkers, and meibomian gland imaging. Therapeutically, anti-inflammatory therapy, meibomian gland heating and expression, and scleral contact lenses are some of the latest options available for treating DED.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Thulasi P, Djalilian AR. Update in Current Diagnostics and Therapeutics of Dry Eye Disease. Ophthalmology. 2017. PMID: 29055359. doi:10.1016/j.ophtha.2017.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。